Shares of UnitedHealth Group ended down 22% Thursday after the health-care giant's first-quarter results fell short of ...

Walgreens Boots Alliance faces significant challenges, including rising inflation, heavy competition, and decreasing ...

CVS Health (CVS) closed the most recent trading ... revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a ...

CVS Health Corporation’s CVS share price has dipped by 6.47%, which has investors questioning if this is right time to buy.

The stock has become the S&P 500’s top performer ... less severe-than-expected medical trends supported the performance. For 2025, CVS Health projects $132 billion in healthcare benefits ...

CVS, Humana and Elevance shares are moving lower on Thursday after UnitedHealth reported earnings prior to the market opening.

CVS HEALTH CORP (CVS) is a large-cap growth stock in the Retail (Drugs) industry. The rating using this strategy is 80% based on the firm’s underlying fundamentals and the stock’s valuation.

CVS Health ( ($CVS) ) has risen by 8.86%. Read on to learn why. CVS Health has experienced a notable stock price increase of ...

The S&P 500 fell 4.3% in the first quarter of 2025, resulting in the worst quarterly performance for U.S. equities in more ...